SeraCare Life Sciences, Inc. (SRLS) Acquires Genomics Collaborative In Stock Deal; Acquisition Strengthens SeraCare BioBank Market Position
10/19/2005 5:11:37 PM
SeraCare Life Sciences, Inc. (Nasdaq: SRLS), a manufacturer and provider of biological materials and services essential for the manufacture of diagnostic tests, commercial bioproduction of therapeutic drugs, and additional research applications, today announced that it has acquired substantially all of the assets of Genomics Collaborative, Inc. ("GCI"), a privately-held company, for approximately 1.1 million shares of unregistered SeraCare common stock, a net cash payment to GCI of approximately $800,000 and the assumption of certain liabilities. The acquisition is expected to be accretive to earnings by the first quarter of fiscal 2005.
comments powered by